Stimulation of Σ1-Receptor Restores Abnormal Mitochondrial Ca2 + Mobilization and ATP Production Following Cardiac Hypertrophy

Hideaki Tagashira,Chen Zhang,Ying-mei Lu,Hideyuki Hasegawa,Hiroshi Kanai,Feng Han,Kohji Fukunaga

DOI: https://doi.org/10.1016/j.bbagen.2012.12.029

2013-01-01

Abstract:Background: We previously reported that the sigma(1)-receptor (sigma R-1) is down-regulated following cardiac hypertrophy and dysfunction in transverse aortic constriction (TAC) mice. Here we address how sigma R-1 stimulation with the selective sigma R-1 agonist SA4503 restores hypertrophy-induced cardiac dysfunction through sigma R-1 localized in the sarcoplasmic reticulum (SR).Methods: We first confirmed anti-hypertrophic effects of SA4503 (0.1-1 mu M) in cultured cardiomyocytes exposed to angiotensin II (Ang II). Then, to confirm the ameliorative effects of sigma R-1 stimulation in vivo, we administered SA4503 (1.0 mg/kg) and the sigma R-1 antagonist NE-100 (1.0 mg/kg) orally to TAC mice for 4 weeks (once daily).Results: sigma R-1 stimulation with SA4503 significantly inhibited Ang II-induced cardiomyocyte hypertrophy. Ang II exposure for 72 h impaired phenylephrine (PE)-induced Ca2+ mobilization from the SR into both the cytosol and mitochondria. Treatment of cardiomyocytes with SA4503 largely restored PE-induced Ca2+ mobilization into mitochondria. Exposure of cardiomyocytes to Mg II for 72 h decreased basal ATP content and PE-induced ATP production concomitant with reduced mitochondrial size, while SA4503 treatment completely restored ATP production and mitochondrial size. Pretreatment with NE-100 or siRNA abolished these effects. Chronic SA4503 administration also significantly attenuated myocardial hypertrophy and restored ATP production in TAC mice. SA4503 administration also decreased hypertrophy-induced impairments in LV contractile function.Conclusions: sigma R-1 stimulation with the specific agonist SA4503 ameliorates cardiac hypertrophy and dysfunction by restoring both mitochondrial Ca2+ mobilization and ATP production via sigma R-1 stimulation.General significance: Our observations suggest that sigma R-1 stimulation represents a new therapeutic strategy to rescue the heart from hypertrophic dysfunction. (C) 2013 Elsevier B.V. All rights reserved.